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Yersinia pestisA B S T R A C T
Plague is a zoonotic disease with a high mortality rate in humans. Unfortunately, it is still ende-
mic in some parts of the world. Also, natural foci of the disease are still found in some countries.
Thus, there may be a risk of global plague re-emergence. This work reviews plague biology, his-
tory of major outbreaks, and threats of disease re-emergence in Egypt. Based on the suspected
presence of potential natural foci in the country, the global climate change, and the threat posed
by some neighbouring countries disease re-emergence in Egypt should not be excluded. The
country is in need for implementation of some preventive measures.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Cairo University.
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Introduction
Plague is a deadly infectious disease which has been responsi-
ble for a number of high-mortality epidemics throughout
human history. Unfortunately, the disease is still endemic in
some parts of the world. Plague natural foci are found in the
tropical and sub-tropical latitudes and the warmer parts of
the temperate latitudes around the globe, between the parallels
55 North and 40 South. Interestingly, known disease natural
foci are found on all continents except Australia [1]. However,
the continent suffered many plague outbreaks originating from
shipping and eventually disappeared. Most probably the dis-
ease did not success to colonise Australia due to its failure to
become established in a suitable enzootic host [2].
Worldwide, humans may be at risk of plague re-emergence.
Due to the high public health signiﬁcance of plague, the pre-
sent work aims at reviewing the disease biology, history of out-
breaks, and threats of disease re-emergence in Egypt.
Biology
Etiologic agent
In 1894, during an epidemic of plague in Hong Kong, a
French-Swiss bacteriologist Alexandre Yersin discovered
the causative agent which is a Gram-negative rod-shaped
enterobacterium. The pathogen is a facultative anaerobe that
can infect humans and other animals. Yersin named it
Pasteurella pestis in honour of the Pasteur Institute where
he worked. In 1967, the organism was moved to a new
genus and renamed Yersinia pestis in honour of Yersin [3].
Yersinia pestis has gained attention as a possible biological
warfare agent [4]. It is one of the ﬁrst examples of biological
warfare in history, when in 1347 plague victims were cata-
pulted by the Mongols over the city walls of Caffa, currently
known as Feodosiya which is located in Ukraine [5]. In
1940, during the World War II, a Japanese airplane released
rice and wheat mixed with rat ﬂeas infected with Y. pestis
over Chushien in Chekiang Province of China. A secondplane load was released three weeks later. These actions
led to a local epidemic that killed 121 persons [6]. During
the 1950s and 1960s, the United States and the former
Soviet Union biological weapons programs developed meth-
ods to directly aerosolise particles containing Y. pestis.
Soviet scientists manufactured large quantities and allegedly
engineered multidrug-resistant strains of the pathogen [7]. It
was estimated that 50 kg of Y. pestis released as an aerosol
over a city of ﬁve million could result in 150,000 cases of
pneumonic plague, with 80,000–100,000 requiring hospitali-
sation and 36,000 deaths [8]. Yersinia pestis has all the qual-
ities you would look for in a potential biological weapon: a
high fatality rate, no vaccine and possible air-borne trans-
mission [7]. Antimicrobial resistance in Y. pestis is rare,
but constitutes a signiﬁcant international public health and
biodefense threat. In 1995, the ﬁrst multidrug resistant iso-
late of Y. pestis was identiﬁed. This strain was resistant to
all ﬁrst-line antibiotics as well as to the principal alternative
drugs for treatment and prophylaxis [9]. The multidrug-
resistant plasmid was highly transferable in vitro to other
strains of Y. pestis, where it was stable. Most probably this
type of replicon can also be transferred among strains of Y.
pestis in their natural environment and, therefore, that resis-
tance may spread locally in this species [9,10].
Life cycle
Yersinia pestis has the ability to cause disease in ﬂeas, rodents
and humans (Fig. 1). The primary carriers of the pathogen are
the Oriental rat ﬂea, Xenopsylla cheopis, and infected rodents.
Xenopsylla cheopis is thought to have originated in Egypt and
during the 19th century spread to all parts of the world as par-
asite of rats infesting ships’ cargos [11]. It was reported that
ﬂeas from other mammals have a role in human plague out-
breaks [12]. Both male and female ﬂeas feed on blood and
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pestis will continue to reproduce and sticking together until a
large plug is formed in the midgut, causing gastrointestinal
functions to cease and the ﬂea to starve. Although the ﬂea can-
not quell its hunger, it bites a host and continues to feed.
Consequently, the ﬂea vomits blood tainted with the bacteria
back into the bite wound. The bacterium then infects a new
victim, and the ﬂea eventually dies from starvation. There
are two cycles for transmission of the disease. The ﬁrst is the
Sylvatic Cycle, or pre-human cycle, which occurs in wild
rodents and ﬂeas. This cycle continues until either all the wild
rodents are dead, or the ﬂeas ﬁnd a new food source, usually
domestic rats. Once a domestic rat gets bitten, or another
domestic animal, the Urban Cycle starts. If a ﬂea that carries
Y. pestis happens to bite a human then that human is infected
[13]. In rare occasions, infected rodents can transmit the infec-
tion to humans through contact. Human to human transmis-
sion of the disease is possible by any of the following means:
droplet contact by coughing or sneezing on another person;
direct physical contact by touching an infected person.
Indirect contact is usually by touching contaminated soil.
Airborne transmission takes place if the causative agent can
remain in the air for long periods [1]. Handling and consump-
tion of raw or insufﬁciently cooked meat of infected animals
like camels and goats were conﬁrmed as means of transmission
of plague to humans [14–17]. Also, the human body louse,
Pediculus humanus corporis, has been proved as an efﬁcient
vector for transmission of Y. pestis [18].
Pathogenicity and clinical picture
There are three main clinical varieties of human infection that
commonly occur worldwide which are bubonic, septicemic,
and pneumonic forms. However, rarely pharyngeal, menin-
geal, cellulocutaneous, pestis minor, asymptomatic, and abor-
tive forms were reported [1,14,20–22].
Bubonic plague is the classic most common in humans.
When an infected ﬂea bites a human and contaminates the
wound with regurgitated blood, the plague carrying bacteria
are passed into the tissue. In human body, the bacteria can
enter the lymphatic system, which drains interstitial ﬂuid. In
lymph nodes, Y. pestis replicates and stimulates severe haem-
orrhagic inﬂammation that causes the nodes to expand to
the size of an egg. The expansion of lymph nodes is the cause
of the characteristic ‘‘buboes’’ associated with the disease.
Lymph nodes expansions typically arise in the groin, neck
and armpits. The disease becomes evident 2–6 days after infec-
tion, and the patients typically experience a sudden onset of ill-
ness characterized by headache, shaking chills, fever, malaise
and pain in the affected regional lymph nodes. Gangrene
may develop in the extremities, lending it the name ‘‘Black
Death’’ [1].
Septicemic plague occurs when Y. pestis is found in the
blood. This form may be either primary or secondary to bubo-
nic plague. The disease is contracted primarily through the bite
of an infected rodent or ﬂea, but like bubonic plague can very
rarely be contracted through an opening in the skin or by
cough from another infected human. After infection, the bac-
teria multiply in the blood, causing bacteraemia and severe
sepsis. It may lead to metastatic infection of other organs or
systems. Complications include plague pneumonia, plaguemeningitis, plague endophthalmitis, hepatic or splenic
abscesses, or generalized lymphadenopathy. Early treatment
with antibiotics reduces the mortality rate to 4–15% [23]. If
not supported, the patient often die on the same day, symp-
toms ﬁrst appear [1,24,25].
Pneumonic plague may be either primary or secondary. The
primary variant is transmitted from human to human through
the air and Y. pestis is then brought directly into the lungs. The
secondary form is a complication of either the bubonic or sep-
ticemic forms. Primary pneumonic plague is the most serious
form of infection. Symptoms, on top of those found in the
other two forms, include a severe cough, coughing with blood
(haemoptysis), chest pains, confusion, cyanosis, shock and
eventual death. The incubation period is usually between two
and four days, but can be as little as a few hours. Without
diagnosis and treatment, the infection can be fatal in one to
six days. It is 100% lethal if not treated [1,26].
Major outbreaks
Historically, it was suggested that the disease had been present
since time immemorial in the areas within or near the Central
Asiatic plateau which was considered as the original home of
the infection [27]. Phylogenetic studies conﬁrmed that the pla-
gue originated in Yunnan province in Southwest China [28].
Plague existed in Egypt and the Nile Valley since the
Pharaonic era [29]. There have been three major human out-
breaks of which are Justinian’s plague (6th and 7th centuries),
the Black Death (14th and 18th centuries), and the third plague
pandemic (1855–1959) [30].
The Plague of Justinian was a pandemic that afﬂicted the
Byzantine Empire. It has been claimed as one of the greatest
plagues in history. The Byzantine historian Procopius ﬁrst
reported the epidemic in 541 A.D. from the port of Pelusium
(near Suez in Egypt). The outbreak in Constantinople was
thought to have been carried to the city by infected rats (and
ﬂeas) on grain boats arriving from Egypt. This epidemic was
nearly worldwide in scope, striking central and south Asia,
North Africa and Arabia; and Europe all the way to
Denmark and Ireland. Throughout the Mediterranean basin,
until about 750 A.D., the epidemic returned in each genera-
tion. About 40% of the population of Constantinople died
from the plague. It was suggested also that half of Europe’s
population was wiped out before the plague disappeared in
the 8th century [30].
The Black Death originated in or near China and spread by
way of the Silk Road or by ship. It may have reduced world
population from an estimated 450 million to between 350
and 375 million in 1400. The pandemic struck various coun-
tries in the Middle East and lead to serious depopulation
and permanent change in both economic and social structures.
As it spread to Western Europe, the disease entered the region
from Southern Russia also. In 1347, the plague reached
Alexandria in Egypt, probably through the port’s trade with
Constantinople, and ports on the Black Sea. During the same
year the disease travelled eastward to Gaza, and north along
the eastern coast to cities in Lebanon, Syria and Palestine,
including Ashkelon, Acre, Jerusalem, Sidon, Damascus,
Homs, and Aleppo. During 1348–49, the disease reached
Antioch. The city’s residents ﬂed to the north, most of them
dying during the journey, but the infection spread to the
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During the same year, records showed that the city of
Mawsil suffered a massive epidemic, and the city of Baghdad
experienced a second round of the disease. In 1351, Yemen
experienced an outbreak of the plague [30].
The third Pandemic spread to all inhabited continents, and
ultimately killed more than 12 million people in India and
China alone. The initial outbreak was in Yunnan Province
(China) in the 1850s [30,31]. According to the World Health
Organization, the pandemic was considered active until 1959,
when worldwide casualties dropped to 200 per year. This pan-
demic may have been from two different sources. The ﬁrst was
primarily bubonic and was carried around the world through
ocean-going trade, through transporting infected persons, rats,
and cargoes harbouring ﬂeas. The second, more virulent strain
was primarily pneumonic in character with a strong person-to-
person contagion. This strain was largely conﬁned to Asia, in
particular Manchuria and Mongolia. In Egypt, the third pan-
demic ﬁrst established itself in the main ports: in Alexandria in
1899 and in Port Said in 1900. It was then dispersed inland
with increasing speed and intensity, reaching its maximum dur-
ing the period 1908–1912. Unlike previous epidemics, the
prevalence was much greater in Upper Egypt than in Lower
Egypt; thus, 6192 cases had been recorded in Upper Egypt
by 1912 as against 2141 in Lower Egypt. The epidemic then
ﬂuctuated widely, although generally lessening, until 1925
when it began to show signs of abating. It disappeared from
the ports (from Suez in 1930, from Port Said in 1932, and from
Alexandria in 1936) and in 1937 from the northern part of
Upper Egypt (the provinces of Giza, Fayoum, Minya, and
Bani Sweif). In 1939, Lower Egypt ﬁnally became free of pla-
gue. In 1941, a control scheme was introduced for rats in river
and canal craft to prevent the disease inland spread from the
ports. So, none was reported inland from 1941 to 1945 despite
an outbreak during that time in the Suez Canal Zone (Port
Said, Suez and Ismailia). During the Alexandria epidemic of
1946–1947, the introduction of DDT and other control mea-
sures resulted in a sharp decrease in ﬂea indices [32].
Recently, DDT resistance was reported in the Egyptian ﬂea
populations of Pulex irritans (the human ﬂea) and X. cheopis
[11].The epidemiological situation of recent epidemics of the
disease in Egypt is not available in the literature. Mollaret
(1995) mentioned the presence of many plague epidemics
which have been negated or dissimulated in order to avoid iso-
lation and quarantine. Among these epidemics were one in
Egypt in 1984 [33].Threats of disease re-emergence in Egypt
In 1999, Tikhomirov reported that natural foci of plague are
known to exist in broad areas of Africa which may include
Egypt [34]. This may be supported by the recent reports of
the presence of natural foci in North Africa in Libya and
Algeria [35–38]. The presence of natural foci of plague plays
a serious role in re-emergence of the disease. Yersinia pestis
bacteria may have been maintained circulating at low levels
in the rodent populations without diagnosis of any human
cases [39]. Also, Y. pestis can survive in the soil under labora-
tory conditions, possibly providing the opportunity for rodents
to be infected and promoting re-emergence of the disease
[40,41]. The new settlements and urbanization may help inre-emergence of plague from potential natural foci, if present.
Surveillance, especially in the western part of Egypt, should be
maintained to monitor the presence of potential natural foci,
and spread of plague that might occur because of environment
inﬂuences.
Climate change including global warming is an emerging
global issue which is expected to signiﬁcantly affect many
countries of the world including Egypt [42–45]. An array of
serious threats is apparent to develop in Egypt with the climate
change, including the increase in water stress, the rise in sea
level, and the rapidly increasing gap between the limited water
availability and the escalating demand for water in the country
[46]. Worldwide, climate has long been incriminated to be a
key factor in the alternation between quiescent and active peri-
ods of plague [47]. Climate affects all components of the pla-
gue cycle (host, vector, and pathogen) in various ways and
over a wide range of scales (from micro-individual ﬂea life
cycle-to macro-a plague area composed of several disjoint foci)
[47]. It was suggested that seasonal variations in temperature
and humidity were responsible for the seasonal patterns of
human plague incidence in India [48]. Also, it was shown that
human plague outbreaks in several African countries were less
frequent when the weather was too hot (>27 C) or cold
(<15 C) [49]. In Vietnam, studies showed an increased plague
incidence during the hot, dry season, when it followed a period
of high seasonal rainfall [50,51]. Unfortunately, the effect of
global climate change especially global warming on re-
emergence of a next round of plague pandemic could not be
excluded.
Libya, a neighbouring country to the west, experienced
several plague outbreaks during the period from 1913 to
1920, the largest of which resulted in 1449 deaths in
Benghazi in 1917. Other epidemics of lower amplitude
occurred in 1972, 1976, and 1977 [52]. The cases diagnosed
during such epidemics were from different parts of the coun-
try scattered over a vast area. This is an evidence that an
extensive epizootic of plague had taken place. Reports of pla-
gue in 1976 in places where sick camels and goats existed
alerted to the role of these animals in the epidemiology of
the disease in some areas [16,52]. More cases of bubonic pla-
gue were diagnosed in 1984 in two locations 25 km from
Tobruk where plague foci had been noted between 1976
and 1977 [38]. After an apparent absence for 25 years, plague
cases recurred in 2009 near Tobruk. An even more recent pla-
gue epidemic was reported in 2011 in the city of Tobruk [35].
The city is very close to the border with Egypt, thus the dan-
ger of plague transmission from its natural foci in Libya to
Egypt should be highlighted.
Israel, a neighbouring country to the east, refused to sign
the 1972 Biological and Toxin Weapons Convention and
maintains a policy of ambiguity regarding government-
sponsored biological weapons research and development.
Speculation about the Israeli biological warfare program
ranging from the mundane to the fantastic [53]. The Ofﬁce
of Technology Assessment in the U.S. Congress listed Israel
as a country ‘‘generally reported as having [an] undeclared
offensive biological warfare [program]’’ [54]. Speculation
about Israel’s biological weapons program focuses on Israel
Institute for Biological Research (IIBR), a highly classiﬁed
defence research centre operated and funded by the
Ministry of Defence’s Division of Research. IIBR’s mission
statement and broad scientiﬁc mandate exemplify the
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IIBR’s publications reveals research on several select agents
and toxins, with special focus on anthrax bacterium and Y.
pestis. Moreover, several other research institutions, including
Hebrew University of Jerusalem, Tel Aviv University, and
Technion also publish select agent research [55]. Even in
the presence of the peace agreements between some Arab
countries and Israel, research and development of biological
weapons pose a threat to the neighbouring countries includ-
ing Egypt.
Conclusions
Plague is a zoonotic disease which continues to pose a major
threat to humanity. Plague re-emergence in Egypt should not
be excluded especially in view of the presence of suspected
potential natural foci, the global climate change, and the threat
posed by some neighbouring countries. Some preventive mea-
sures should be implemented, including surveillance of sus-
pected natural foci, rodent and insect eradication campaigns,
public health education, immunization, and genetic analysis
of Y. pestis strains whenever found.Conﬂict of interest
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